Myeloid Ther­a­peu­tics goes down un­der for new man­u­fac­tur­ing site, with $66M lo­cal in­vest­ment

Myeloid Ther­a­peu­tics is look­ing across the Pa­cif­ic to es­tab­lish a new man­u­fac­tur­ing site, and will be net­ting some ma­jor as­sis­tance from the lo­cal gov­ern­ment as well.

The Cam­bridge, MA-based biotech an­nounced that it is col­lab­o­rat­ing with the gov­ern­ment of New South Wales in Aus­tralia to build a new RNA man­u­fac­tur­ing and re­search fa­cil­i­ty. The fa­cil­i­ty will aim to speed up the com­mer­cial­iza­tion of Myeloid’s RNA ther­a­peu­tics, with the New South Wales gov­ern­ment in­vest­ing AU 96 mil­lion ($65.7 mil­lion) in­to the fa­cil­i­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER